Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,665 | 9 | 4,732 | 5,221 | 2,543 |
| Marketable Securities | N/A | N/A | 419 | 1,749 | 2,634 |
| TOTAL | $2,097 | $312 | $5,569 | $7,838 | $5,757 |
| Non-Current Assets | |||||
| PPE Net | N/A | 4 | N/A | N/A | N/A |
| Other Non-Current Assets | 0 | 67 | 0 | 169 | 187 |
| TOTAL | $N/A | $71 | $N/A | $169 | $187 |
| Total Assets | $2,097 | $383 | $5,569 | $8,007 | $5,944 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 528 | 1,294 | 1,185 | 1,810 | 1,233 |
| Accrued Expenses | 1,353 | 36 | 700 | 854 | 1,205 |
| Other current liabilities | 185 | 5 | 225 | 1,658 | 100 |
| TOTAL | $2,066 | $1,994 | $2,110 | $4,322 | $2,538 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 14 | 0 | 19 | 46 |
| TOTAL | $N/A | $14 | $N/A | $19 | $46 |
| Total Liabilities | $2,066 | $2,008 | $2,110 | $4,341 | $2,584 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2 | 0 | 0 | 0 | 0 |
| Common Shares | N/A | N/A | 1 | 1 | N/A |
| Retained earnings | -31,322 | -18,496 | -27,343 | -26,310 | -24,537 |
| Other shareholders' equity | 0 | 0 | -1 | -3 | -6 |
| TOTAL | $31 | $-1,625 | $3,459 | $3,666 | $3,360 |
| Total Liabilities And Equity | $2,097 | $383 | $5,569 | $8,007 | $5,944 |